Mayne Pharma Group Limited (HG6.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 08:12AM CEST
| Previous Close | 4.2600 |
| Open | 4.2800 |
| Bid | 4.2800 x 1000000 |
| Ask | 4.3600 x 1000000 |
| Day's Range | 4.2800 - 4.2800 |
| 52 Week Range | 1.6300 - 4.4400 |
| Volume | |
| Avg. Volume | 12 |
| Market Cap | 367.782M |
| Beta (5Y Monthly) | 1.32 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jan 18, 2023 |
| 1y Target Est | N/A |
- GlobeNewswire
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ADELAIDE, Australia, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Mayne Pharma Group Limited (ASX: MYX) today announced that Shawn Patrick O’Brien, Chief Executive Officer of Mayne Pharma, will present at the 42nd Annual J.P. Morgan Healthcare Conference as follows: Date: Thursday, January 11, 2024Time: 7:30am PST / 10:30 am ESTWebcast: Click here The live and archived webcast of the presentation will be accessible from the Company’s website www.maynepharma.com under Investor Relations. The replay of the w
© 2024 Yahoo. All rights reserved.